RB

Rishi Bhandari

Active Director Director DIN 03367785
DIN 03367785 First appointment Dec 2010 Primary industry Environment
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2010
Shareholding value •••• Premium profile

About Rishi Bhandari

Data last updated:

Rishi Bhandari is a Director at Vivek Pharmachem (India) Limited (since 2024) and Director at Medi Rasayan Private Limited (since 2010). The companies operate in Environment and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹252 Cr; the largest is Vivek Pharmachem (India) Limited at ₹246 Cr (FY 2025).

DIN 03367785
Primary Designation Director
Industry Environment
First Appointment 22 Dec 2010
Oldest Company Age 36 yrs
Largest company Vivek Pharmachem (India) Limited · ₹246 Cr (FY 2025)
Combined revenue ₹252 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vivek Pharmachem (India) Limited U24232RJ1990PLC005283
Director24 Dec 20241990₹246 Cr (FY 2025)Active
Medi Rasayan Private Limited U24231TN1990PTC019136
Director22 Dec 20101990₹6.12 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Medi Rasayan Private Limited
Vivek Pharmachem (India) Limited
Premium access

Shareholding and investment profile for Rishi Bhandari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rishi Bhandari

Rishi Bhandari currently holds 2 directorships: Vivek Pharmachem (India) Limited (Director, since 24 Dec 2024, revenue ₹246 Cr (FY 2025)); Medi Rasayan Private Limited (Director, since 22 Dec 2010, revenue ₹6.12 Cr (FY 2024)).

Rishi Bhandari was first appointed on 22 Dec 2010 as Director at Medi Rasayan Private Limited. The most recent appointment on record is 24 Dec 2024 at Vivek Pharmachem (India) Limited.

The 2 current companies of Rishi Bhandari that report revenue have a combined latest revenue of ₹252 Cr: Vivek Pharmachem (India) Limited ₹246 Cr (FY 2025); Medi Rasayan Private Limited ₹6.12 Cr (FY 2024).

The current boards of Rishi Bhandari's companies include Aruna Gupta (Vivek Pharmachem (India) Limited), Ashwin Gupta (Vivek Pharmachem (India) Limited), Ashwin Gupta (Vivek Pharmachem (India) Limited), Harshit Garg (Vivek Pharmachem (India) Limited), Kuldeep Gupta (Vivek Pharmachem (India) Limited), Navdeep Gupta (Vivek Pharmachem (India) Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available